KeyMed Biosciences Inc 2162.HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 4:09 PM CTT
34.95quote price arrow up+1.30 (+3.86%)
Volume
1,411,000
52 week range
26.60 - 65.60
Loading...
  • Open33.65
  • Day High35.30
  • Day Low33.20
  • Prev Close33.65
  • 52 Week High65.60
  • 52 Week High Date05/05/23
  • 52 Week Low26.60
  • 52 Week Low Date04/22/24

Key Stats

  • Market Cap969.54M
  • Shares Out276.7M
  • 10 Day Average Volume1.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change-28.82

KEY STATS

  • Open33.65
  • Day High35.30
  • Day Low33.20
  • Prev Close33.65
  • 52 Week High65.60
  • 52 Week High Date05/05/23
  • 52 Week Low26.60
  • 52 Week Low Date04/22/24
  • Market Cap969.54M
  • Shares Out276.7M
  • 10 Day Average Volume1.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change-28.82

RATIOS/PROFITABILITY

  • EPS (TTM)-1.51
  • P/E (TTM)-23.10
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On KeyMed Biosciences Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Keymed Biosciences Inc is a China-based biotechnology company. The Company focuses on the independent discovery and development of innovative biological therapies that address underserved medical needs in the autoimmune and oncology therapeutic areas. The Company has mastered in-house drug discovery and development technologies, including an innovative antibody discovery platform and a proprietary novel T cell engager (nTCE) bispecific antibody platform. The Company has also...
Bo Chen
Executive Chairman of the Board, Chief Executive Officer
Yanrong Zhang
Chief Financial Officer, Company Secretary
Qian Jia
Vice President
Address
18 Biotown Middle Road Building D2
Chengdu Tianfu International Biotown
Chengdu, SIC
610219
China